Immunization programs save hundreds of thousands of lives in the developing world, and the introduction of new vaccines will save millions more. As new, more expensive vaccines enter the global market, however, many developing countries are struggling to finance their immunization programs. To address this growing challenge, the Sabin Vaccine Institute has launched its latest initiative: the Advocacy Project for Sustainable Immunization Financing.
Sabin has grown over the last few years and continues to do so with the success and momentum of its programs aimed at combating infectious and neglected diseases. Scroll through the new faces of Sabin's leadership, executive members and staff to see the new talent helping to build healthier nations.
What are the Neglected Infections of Poverty?
Reykjavik, Iceland – Nearly 1,000 of the world’s leading experts on infectious diseases and vaccines are meeting during the 6th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-6) this week to call for renewed and urgent action by governments to protect their citizens against pneumococcal disease, a leading killer of children and adults worldwide.
At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.
The National Partnership for Immunization will be hosting an informational conference call, offering media an opportunity to hear about current childhood vaccine safety issues and ask questions of vaccine experts.
Prof. Dr. Ciro A. de Quadros, co-chairman of the Pneumococcal Awareness Council of Experts (PACE), stated that there are seven children dying from diseases caused by pneumococcus bacteria every minute, pointing out that the pneumococcal conjugate vaccination was effective and safe in preventing such diseases.